For the first time, we found that the BM microenvironment immune phenotype was related to the fatty acid metabolism gene ECHDC3, which might contribute to its negative effect on the survival of AML patients by inhibiting NK function, which remained to be explored in vivo and in vitro research in near future. This evidence concerns the gene ECHDC3 and acute myeloid leukemia.